Differential baseline expression and angiotensin II-stimulation of leukemia-associated RhoGEF in vascular smooth muscle cells of spontaneously hypertensive rats

International Journal of Nanomedicine

Volumn 7, Issue , 2012, Pages 5929-5939

  Chiu, Wei Chiao ^a   Juang, Jyh Ming ^a   Chang, Shen Nan ^a   Wu, Cho Kai ^a   Tsai, Chia Ti ^a   Tseng, Chuen Den ^a   Tseng, Yung Zu ^a   Su, Ming Jai ^a   Chiang, Fu Tien ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Hypertension; Leukemia associated Rho guanine nucle otide exchange factor; Nanoparticle delivery; Rho guanine nucleotide exchange factor; Wistar Kyoto rats

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II; ANGIOTENSIN II DERIVATIVE; GUANINE NUCLEOTIDE EXCHANGE FACTOR; MESSENGER RNA; NANOPARTICLE; RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR; RHO KINASE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; ARHGEF12 PROTEIN, RAT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; ENZYME REGULATION; GENE DELIVERY SYSTEM; GENE SILENCING; HYPERTENSION; LEUKEMIA; MALE; NANOTECHNOLOGY; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; ANIMAL; CELL CULTURE; DRUG EFFECT; GENE EXPRESSION REGULATION; METABOLISM; SPONTANEOUSLY HYPERTENSIVE RAT; WISTAR RAT;

RATTUS;

ANGIOTENSIN II; ANIMALS; CELLS, CULTURED; GENE EXPRESSION REGULATION; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HYPERTENSION; MALE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; RATS; RATS, INBRED SHR; RATS, WISTAR;

EID: 84875873389     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S36700     Document Type: Article

References (36)

1. Guilluy C, Brégeon J, Toumaniantz G, et al. The Rho exchange factor Arhgef1 mediates the effects of angiotensin II on vascular tone and blood pressure. Nat Med. 2010;16(2):183-190.
2. Moriki N, Ito M, Seko T, et al. RhoA activation in vascular smooth muscle cells from stroke-prone spontaneously hypertensive rats. Hypertens Res. 2004;27(4):263-270.
3. Uehata M, Ishizaki T, Satoh H, et al. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature. 1997;389(6654):990-994.
4. Somlyo AP, Somlyo AV. Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. Physiol Rev. 2003;83(4):1325-1358.
5. Somlyo AP, Somlyo AV. Signal transduction by G-proteins, Rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II. J Physiol. 2000;522 Pt 2:177-185.
6. Ying Z, Giachini FR, Tostes RC, Webb RC. Salicylates dilate blood vessels through inhibiting PYK2-mediated RhoA/Rho-kinase activation. Cardiovasc Res. 2009;83(1):155-162.
7. Wirth A, Benyó Z, Lukasova M, et al. G12-G13-LARG-mediated signaling in vascular smooth muscle is required for salt-induced hypertension. Nat Med. 2008;14(1):64-68.
8. Hilgers RH, Todd J Jr, Webb RC. Increased PDZ-RhoGEF/RhoA/Rho kinase signaling in small mesenteric arteries of angiotensin II-induced hypertensive rats. J Hypertens. 2007;25(8):1687-1697.
9. Rossman KL, Der CJ, Sondek J. GEF means go: turning on Rho GTPases with guanine nucleotide-exchange factors. Nat Rev Mol Cell Biol. 2005;6(2):167-180.
10. Bos JL, Rehmann H, Wittinghofer A. GEFs and GAPs: critical elements in the control of small G proteins. Cell. 2007;129(5):865-877.
11. Jaiswal M, Gremer L, Dvorsky R, et al. Mechanistic insights into specificity, activity, and regulatory elements of the regulator of G-protein signaling (RGS)-containing Rho-specific guanine nucleotide exchange factors (GEFs) p115, PDZ-RhoGEF (PRG), and leukemia-associated RhoGEF (LARG). J Biol Chem. 2011;286(20):18202-18212.
12. Ito K, Hirooka Y, Sakai K, et al. Rho/Rho-kinase pathway in brain stem contributes to blood pressure regulation via sympathetic nervous system: possible involvement in neural mechanisms of hypertension. Circ Res. 2003;92(12):1337-1343.
13. Yang RH, Jin HK, Wyss JM, Chen YF, Oparil S. Salt supplementation does not alter the pressor effect of blocking atrial natriuretic peptide in nucleus tractus solitarii. Hypertension. 1992;20(2):242-246.
14. Bunkenburg B, van Amelsvoort T, Rogg H, Wood JM. Receptor-mediated effects of angiotensin II on growth of vascular smooth muscle cells from spontaneously hypertensive rats. Hypertension. 1992;20(6): 746-754.
15. Ying Z, Jin L, Dorrance AM, Webb RC. Increaseed expression of mRNA for regulator of G protein signaling domain-containing Rho guanine nucleotide exchange factors in aorta from stroke-prone spontaneously hypertensive rats. Am J Hypertens. 2004;17(10):981-985.
16. Chiu W-C, Juang J-M, Chang S-N, et al. Angiotensin II regulates LARG/RhoA/MYPT1 axis in rat vascular smooth muscle. Acta Pharmacol Sin. In press 2012.
17. Guo P, Coban O, Snead NM, et al. Engineering RNA for targeted siRNA delivery and medical application. Adv Drug Deliv Rev. 2010;62(6): 650-666.
18. Gao Y, Liu XL, Li XR. Research progress on siRNA delivery with nonviral carriers. Int J Nanomedicine. 2011;6:1017-1025.
19. Ross R. The smooth muscle cell: II. Growth of smooth muscle in culture and formation of elastic fibers. J Cell Biol. 1971;50(1):172-186.
20. Eguchi S, Hirata Y, Imai T, Kanno K, Marumo F. Phenotypic change of endothelin receptor subtype in cultured rat vascular smooth muscle cells. Endocrinology. 1994;134(1):222-228.
21. Eguchi S, Numaguchi K, Iwasaki H, et al. Calcium-dependent epidermal growth factor receptor transactivation mediates the angiotensin II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells. J Biol Chem. 1998;273(15):8890-8896.
22. Yamakawa T, Tanaka S, Numaguchi K, et al. Involvement of Rho-kinase in angiotensin II-induced hypertrophy of rat vascular smooth muscle cells. Hypertension. 2000;35(1 Pt 2):313-318.
23. Alameh M, Jean M, DeJesus D, Buschmann MD, Merzouki A. Chi-tosanase-based method for RNA isolation from cells transfected with chitosan/siRNA nanocomplexes for real-time RT-PCR in gene silencing. Int J Nanomedicine. 2010;5:473-481.
24. Ying Z, Jin L, Palmer T, Webb RC. Angiotensin II up-regulates the leukemia-associated Rho guanine nucleotide exchange factor (RhoGEF), a regulator of G protein signaling domain-containing RhoGEF, in vascular smooth muscle cells. Mol Pharmacol. 2006;69(3):932-940.
25. Ying Z, Giachini FR, Tostes RC, Webb RC. PYK2/PDZ-RhoGEF links Ca2+ signaling to RhoA. Arterioscler, Thromb Vasc Biol. 2009;29(10): 1657-1663.
26. Lodi F, Cogolludo A, Duarte J, et al. Increased NADPH oxidase activity mediates spontaneous aortic tone in genetically hypertensive rats. Eur J Pharmacol. 2006;544(1-3):97-103.
27. Guilluy C, Rolli-Derkinderen M, Loufrani L, et al. Ste20-related kinase SLK phosphorylates Ser188 of RhoA to induce vasodilation in response to angiotensin II type 2 receptor activation. Circ Res. 2008;102(10): 1265-1274.
28. Sun D, Yan C, Jacobson A, Jiang H, Carroll MA, Huang A. Contribution of epoxyeicosatrienoic acids to flow-induced dilation in arteries of male ERalpha knockout mice: role of aromatase. Am J Physiol Regul Integr Comp Physiol. 2007;293(3):R1239-R1246.
29. Toumaniantz G, Ferland-McCollough D, Cario-Toumaniantz C, Pacaud P, Loirand G. The Rho protein exchange factor Vav3 regulates vascular smooth muscle cell proliferation and migration. Cardiovasc Res. 2010;86(1):131-140.
30. Oh YK, Park TG. siRNA delivery systems for cancer treatment. Adv Drug Deliv Rev. 2009;61(10):850-862.
31. Shimizu E, Ohyanagi M, Masutani M, Iwasaki T. A decrease in the amount and function of the stimulatory GTP-binding protein in the small resistance arteries of spontaneously hypertensive rats. Hypertens Res. 2002;25(5):743-749.
32. Asano M, Nomura Y. Calcium buffering of resting, voltage-dependent Ca2+ influx by sarcoplasmic reticulum in femoral arteries from spontaneously hypertensive rats at prehypertensive stage. Hypertens Res. 2001;24(3):271-282.
33. Asano M, Nomura Y. Ca2+ buffering function of the sarcoplasmic reticulum is increased in the carotid artery from spontaneously hypertensive rats. Hypertens Res. 2002;25(2):221-230.
34. Brunner HR, Chang P, Wallach R, Sealey JE, Laragh JH. Angiotensin II vascular receptors: their avidity in relationship to sodium balance, the autonomic nervous system, and hypertension. J Clin Invest. 1972;51(1): 58-67.
35. Schoner W. Salt abuse: the path to hypertension. Nat Med. 2008;14(1): 16-17.
36. Evelyn CR, Ferng T, Rojas RJ, Larsen MJ, Sondek J, Neubig RR. High-throughput screening for small-molecule inhibitors of LARG-stimulated RhoA nucleotide binding via a novel fluorescence polarization assay. J Biomol Screen. 2009;14(2):161-172.